Francesco Calderaro

542 total citations
12 papers, 408 citations indexed

About

Francesco Calderaro is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Francesco Calderaro has authored 12 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Physiology and 2 papers in Molecular Biology. Recurrent topics in Francesco Calderaro's work include Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Asthma and respiratory diseases (6 papers) and Inhalation and Respiratory Drug Delivery (3 papers). Francesco Calderaro is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Asthma and respiratory diseases (6 papers) and Inhalation and Respiratory Drug Delivery (3 papers). Francesco Calderaro collaborates with scholars based in Italy, Argentina and Japan. Francesco Calderaro's co-authors include Mario Cazzola, F. Di Perna, Maria Gabriella Matera, Antonello Salzillo, Francesco Imperatore, Annamaria Vinciguerra, Stefano Centanni, R. Testi, Gabriele Di Lorenzo and Paolo Tini and has published in prestigious journals such as CHEST Journal, European Respiratory Journal and Journal of Cellular Biochemistry.

In The Last Decade

Francesco Calderaro

11 papers receiving 386 citations

Peers

Francesco Calderaro
Ilse G.M. Slot Netherlands
Lisa K. Kelly United States
Lasse Ramsgaard United States
Mark I. Allenby United Kingdom
Disha Joshi United States
Ilse G.M. Slot Netherlands
Francesco Calderaro
Citations per year, relative to Francesco Calderaro Francesco Calderaro (= 1×) peers Ilse G.M. Slot

Countries citing papers authored by Francesco Calderaro

Since Specialization
Citations

This map shows the geographic impact of Francesco Calderaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Calderaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Calderaro more than expected).

Fields of papers citing papers by Francesco Calderaro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Calderaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Calderaro. The network helps show where Francesco Calderaro may publish in the future.

Co-authorship network of co-authors of Francesco Calderaro

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Calderaro. A scholar is included among the top collaborators of Francesco Calderaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Calderaro. Francesco Calderaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Lugarà, Marina, Gabriella Oliva, Francesco Calderaro, et al.. (2023). Adjunctive use of oral MAF is associated with no disease progression or mortality in hospitalized patients with COVID-19 pneumonia: The single-arm COral-MAF1 prospective trial. Biomedicine & Pharmacotherapy. 169. 115894–115894.
2.
Calderaro, Francesco, et al.. (2021). Successful Treatment of Iron Deficiency Anemia with Ferric Carboxymaltose in an Elderly Patient with Multiple Comorbidities and COVID-19. Cureus. 13(8). e16997–e16997. 1 indexed citations
4.
Palumbo, Silvia, Luigi Pirtoli, Paolo Tini, et al.. (2012). Different involvement of autophagy in human malignant glioma cell lines undergoing irradiation and temozolomide combined treatments. Journal of Cellular Biochemistry. 113(7). 2308–2318. 61 indexed citations
5.
Conti, Ilaria, Francesco Calderaro, Luisa Beltran, et al.. (2008). Multicentre Evaluation of the Second Generation Elecsys NT-proBNP Assay. 32(5). 458–458. 3 indexed citations
6.
Cazzola, Mario, Gabriele Di Lorenzo, F. Di Perna, et al.. (2000). Additive Effects of Salmeterol and Fluticasone or Theophylline in COPD. CHEST Journal. 118(6). 1576–1581. 59 indexed citations
7.
Cazzola, Mario, Annamaria Vinciguerra, F. Di Perna, et al.. (1999). Comparative Study of Dirithromycin and Azithromycin in the Treatment of Acute Bacterial Exacerbations of Chronic Bronchitis. Journal of Chemotherapy. 11(2). 119–125. 14 indexed citations
8.
Cazzola, Mario, et al.. (1999). Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease. European Journal of Clinical Pharmacology. 54(11). 829–833. 19 indexed citations
9.
Cazzola, Mario, Francesco Imperatore, Antonello Salzillo, et al.. (1998). Cardiac Effects of Formoterol and Salmeterol in Patients Suffering from COPD with Preexisting Cardiac Arrhythmias and Hypoxemia. CHEST Journal. 114(2). 411–415. 144 indexed citations
10.
Cazzola, Mario, et al.. (1998). A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease. Respiratory Medicine. 92(2). 354–357. 26 indexed citations
11.
Cazzola, Mario, F. Di Perna, Paolo Noschese, et al.. (1998). Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD. European Respiratory Journal. 11(6). 1337–1341. 35 indexed citations
12.
Matera, Maria Gabriella, Mario Cazzola, Annamaria Vinciguerra, et al.. (1995). A comparison of the bronchodilating effects of salmeterol, salbutamol and Ipratropium bromide in patients with chronic obstructive pulmonary disease. Pulmonary Pharmacology. 8(6). 267–271. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026